PMS19 COST-EFFECTIVENESS OF USING ETANERCEPT AS FIRST LINE...

Value in Health 2008 Vol. 11; Iss. 6

PMS19 COST-EFFECTIVENESS OF USING ETANERCEPT AS FIRST LINE IN SEVERE AND HIGHLY ACTIVE RHEUMATOID ARTHRITIS (RA)

H Miadi-Fargier, B Fautrel, M Maravic, JP Daures, AL Ollivier, C Le Pen, F Maurel
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)66787-3
File:
PDF, 98 KB
english, 2008
Conversion to is in progress
Conversion to is failed